Fischer Medical Ventures Ltd — Board Meeting, 30-05-2026: Board Meeting
30-05-2026 | 01:54 am
30-05-2026 | 01:54 am
Fischer Medical Ventures reported FY26 consolidated revenue of ₹308.58 Cr and net profit of ₹30.97 Cr. Q4 consolidated net loss was ₹7.10 Cr. Board proposed a final dividend of ₹0.05/share for FY26.
No comments yet. Be the first to comment!
